FDA 483 - Computer Programs & Systems Inc - September 13, 2023

An FDA inspection of Computer Programs & Systems Inc. in Mobile, AL, a medical device manufacturer, identified three significant quality system deficiencies. The firm failed to establish adequate procedures for design control and statistical techniques for its Blood Establishment Computer Software. Additionally, the company did not properly document corrective and preventive actions related to programming changes and software updates.